Picosun Oy – Trademark Portfolio

Entity Type: 99

Picosun Oy holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 7 (Machinery) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include PICOSUN and PICOMEDICAL. The owner is based in Espoo.

Tietotie 3

Espoo FI-02150 , FI

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Picosun Oy's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

7
Machinery (4 filings)

Machines and machine tools; motors and engines; machine coupling and transmission components

40
Treatment & Processing (4 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does Picosun Oy have?

Picosun Oy has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does Picosun Oy file in?

Picosun Oy files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 7 (Machinery), Class 40 (Treatment & Processing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Picosun Oy's most well-known trademarks?

Picosun Oy's registered trademark portfolio includes well-known marks such as PICOSUN and PICOMEDICAL. These are among 2 currently registered trademarks in the portfolio.

What is Picosun Oy's trademark registration success rate?

Picosun Oy has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.